| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $126K | +105.1% |
| R&D Expense | $158K | +330.8% |
| SG&A Expense | $28K | -76.5% |
| Operating Income | -$340K | -69.2% |
| Interest Expense | $139K | -56.1% |
| Net Income | $2.4M | +136.1% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51K | -93.0% |
| Accounts Receivable | $254K | +19.3% |
| Current Assets | $336K | -66.2% |
| Total Assets | $559K | -53.9% |
| Current Liabilities | $8.6M | -41.5% |
| Total Liabilities | $8.6M | -41.5% |
| Stockholders' Equity | -$8.0M | +40.4% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $607K | +153.7% |
| Investing Cash Flow | $25K | -94.9% |
| Financing Cash Flow | -$94K | -106.9% |